ATE171454T1 - Verfahren zur herstellung von cefixime trihydrat - Google Patents

Verfahren zur herstellung von cefixime trihydrat

Info

Publication number
ATE171454T1
ATE171454T1 AT95921739T AT95921739T ATE171454T1 AT E171454 T1 ATE171454 T1 AT E171454T1 AT 95921739 T AT95921739 T AT 95921739T AT 95921739 T AT95921739 T AT 95921739T AT E171454 T1 ATE171454 T1 AT E171454T1
Authority
AT
Austria
Prior art keywords
tert
producing
cepheme
butoxycarbonylmethoxyimino
aminothiazol
Prior art date
Application number
AT95921739T
Other languages
English (en)
Inventor
Dardes Carlos Picornell
Original Assignee
Marcham Trading & Investment L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcham Trading & Investment L filed Critical Marcham Trading & Investment L
Application granted granted Critical
Publication of ATE171454T1 publication Critical patent/ATE171454T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT95921739T 1994-06-03 1995-05-10 Verfahren zur herstellung von cefixime trihydrat ATE171454T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01751/94A CH688319A5 (fr) 1994-06-03 1994-06-03 Procédé pour la préparation du céfixime trihydraté.

Publications (1)

Publication Number Publication Date
ATE171454T1 true ATE171454T1 (de) 1998-10-15

Family

ID=4217712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921739T ATE171454T1 (de) 1994-06-03 1995-05-10 Verfahren zur herstellung von cefixime trihydrat

Country Status (9)

Country Link
EP (1) EP0763043B1 (de)
KR (1) KR100223384B1 (de)
AT (1) ATE171454T1 (de)
AU (1) AU2670295A (de)
CH (1) CH688319A5 (de)
DE (1) DE69504971T2 (de)
ES (1) ES2120911B1 (de)
PE (1) PE13296A1 (de)
WO (1) WO1995033753A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
AT404251B (de) * 1996-08-14 1998-10-27 Biochemie Gmbh Neues kristallines salz von cefixim
PT102061B (pt) * 1997-10-08 2000-06-30 J K Ind Ltd Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography
DE602005012866D1 (de) * 2004-12-21 2009-04-02 Lupin Ltd Verfahren zur hestellung von cefixim
ES2334685T3 (es) 2005-03-29 2010-03-15 Hetero Drugs Limited Procedimiento mejorado de preparacion de cefixima.
CN1312158C (zh) * 2005-05-20 2007-04-25 天津市医药集团技术发展有限公司 一种头孢克肟的制备方法
WO2016142902A1 (en) * 2015-03-11 2016-09-15 Lupin Limited Cefixime with reduced surface area and high stability
CN111039958B (zh) * 2017-05-31 2022-05-20 郑州大学第一附属医院 头孢地尼的制备方法
JP2023011144A (ja) 2021-07-12 2023-01-24 ウシオ電機株式会社 光源装置、誘電体バリア放電ランプの点灯回路、誘電体バリア放電ランプの点灯方法
CN113968874B (zh) * 2021-10-29 2023-01-31 国药集团威奇达药业有限公司 头孢克肟的精制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
ES2120911A1 (es) 1998-11-01
AU2670295A (en) 1996-01-04
DE69504971T2 (de) 1999-05-20
KR970703348A (ko) 1997-07-03
WO1995033753A1 (fr) 1995-12-14
DE69504971D1 (de) 1998-10-29
EP0763043A1 (de) 1997-03-19
CH688319A5 (fr) 1997-07-31
PE13296A1 (es) 1996-05-10
ES2120911B1 (es) 1999-07-01
KR100223384B1 (ko) 1999-10-15
EP0763043B1 (de) 1998-09-23

Similar Documents

Publication Publication Date Title
ATE171454T1 (de) Verfahren zur herstellung von cefixime trihydrat
DE4419591B4 (de) Verfahren zur Herstellung eines plastisch geformten Produkts
DE69517832D1 (de) Ein Verfahren zur Herstellung von Tetrazolyl-Verbindungen
ATE194341T1 (de) Verfahren zur herstellng von cyano- methoxyiminomethylderivaten
ATE116284T1 (de) Verfahren zur o-alkylierung von n- (hydroxy)aralkylphenylethanolamin.
ATE167677T1 (de) Verfahren zur reinigung von roher clavulansäure
DE69517201T2 (de) Verfahren zur herstellung von 2-(2-hydroxymethylphenyl)acetamid-derivaten und zwischenprodukte zur herstellung
ATE154803T1 (de) Verfahren zur herstellung von 2-amino-6- chloropurin und derivaten
DE69304638D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan
DE3667294D1 (de) Verfahren zur herstellung einer uebergangsmetallkomponente fuer ein olefinpolymerisationskatalysatorsystem.
DE69811893T2 (de) Verfahren zur herstellung von azetidin-2-carbonsäure und zwischenprodukten davon
ATE402940T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
ATE226570T1 (de) Verfahren zur herstellung von halogenacetamidderivaten
ATE159519T1 (de) Verfahren zur herstellung von n-phenyl-n-(4- piperidinyl)amid-derivaten
DE69420654T2 (de) Verfahren zur Herstellung eines Hydrofluorokohlenwasserstoffs
ATE200776T1 (de) Verfahren zur herstellung von 2,4,5-tribrompyrrol-3-carbonitril
ATE172964T1 (de) Verfahren zur herstellung von (-)-n-methyl-n-(4- (4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4- dichlorophenyl)butyl>-benzamid und ihr pharmazeutisch annehmbares salz
ATE259799T1 (de) Verfahren zur herstellung von 2-(tetrazol-5-yl)-4-oxo-4h-benzopyranen
ATE158284T1 (de) Verfahren zur herstellung von nepinolon
ATE161822T1 (de) Verfahren zur herstellung von (s)-4-aminohepta- 5,6-diencarbon-säure und intermediate
DE69504133T2 (de) Verfahren zur Rückgewinnung eines benutzten sauren Katalysators
DE69416117T2 (de) Verfahren zur herstellung von kondensierten carbapenemderivaten
ATE194840T1 (de) Verfahren zur herstellung von antifolaten 4- hydroxypyrrolo 2,3-d pyrimidinderivaten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE240933T1 (de) Verfahren zum herstellen von alpha- arylalkansäuren

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee